Liquid Biopsy Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Liquid Biopsy Market
Liquid Biopsy Market: Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), End User (Reference Laboratory, Research Centers) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0292
Updated Date: 31 May, 2018  

1. Liquid Biopsy Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Liquid Biopsy Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing cases of new cancer patients
      4.1.2. Benefits of Liquid Biopsy Over Surgical Biopsy
   4.2. Restraints
      4.2.1. Low Sensitivity and Specificity
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Liquid Biopsy Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Liquid Biopsy Market, By Cancer Type
   6.1. Lung Cancer
   6.2. Breast Cancer
   6.3. Colorectal Cancer
   6.4. Prostate Cancer
   6.5. Liver Cancer
   6.6. Other Cancers
7. Liquid Biopsy Market, By Circulating Biomarker
   7.1. Circulating Tumor Cells
   7.2. Extracellular Vesicles
   7.3. Circulating Tumor DNA (CTDNA)
   7.4. Other Biomarkers
8. Liquid Biopsy Market, By End-User
   8.1. Reference Laboratory,
   8.2. Research Centers
9. Liquid Biopsy Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Liquid Biopsy – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Biocept, Inc.
   11.2. Qiagen
   11.3. F. Hoffmann-La Roche AG
   11.4. Bio-Rad Laboratories Inc.
   11.5. Myriad Genetics
   11.6. Janssen Diagnostics, LLC.
   11.7. Tr0vagene Inc.
   11.8. Guardant Health Inc.
   11.9. Fraunhofer-Gesellschaft
   11.10. MDX Health SA
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll